Skip to main content

Latest SEC Filings — Page 187

Page 187 · 30 filings scored 7+ · newest 8:30 AM ET · How scores work

Thu, Aug 1330 filings
8CABRCaring Brands, Inc.Caring Brands 10-Q Reveals Material Weaknesses, Going Concern, and Nasdaq Delisting RiskForm 10-Q · Periodic report▼ NegativePro8KTWOK2 Capital Acquisition CorpK2 Capital Flags Going Concern Doubt as SPAC Deadline LoomsForm 10-Q · Periodic report▼ NegativePro7DUKRDUKE Robotics Corp.Q2 Loss Widens to $726K, but $9.2M Offering Extends Cash RunwayForm 10-Q · Periodic report● Neutral7CADLCandel Therapeutics, Inc.Candel Q2 Loss Widens to $38.9M; Cash Runway Extended to Q1 2028Form 10-Q · Periodic report● Neutral7HTCRHeartCore Enterprises, Inc.HeartCore Q2 Revenue Up 72% but Net Loss Widens to $2M; Cash Drops to $587KForm 8-K · Current report▼ Negative7PARABanzai International, Inc.Banzai Closes $1.1M Convertible Note at $1.96, Deep Discount to Prior $2.75Form 8-K · Current report▼ Negative8ONDSOndas Inc.Ondas Posts Record Q2 Revenue of $83.8M, Raises Full-Year Outlook to $525–$550MForm 8-K · Current report▲ PositivePro8DFSCDEFSEC Technologies Inc.DEFSEC Q3 Revenue Up 92%, BLISS™ Passes U.S. Army TestingForm 6-K · Current report▲ PositivePro8SNDASonida Senior Living, Inc.Sonida Secures $380M Term Loan to Refinance Debt and Extend MaturityForm 8-K · Current report● NeutralPro7LUCDLucid Diagnostics Inc.Lucid Diagnostics Q2 2026: Revenue Climbs 27% and First LBM Coverage Policy SecuredForm 8-K · Current report● Neutral8MGTXMeiraGTx Holdings plcMeiraGTx Q2 2026: $160.7M Profit, Cash Runway to H2 2028, Oberland Capital Deal DetailsForm 10-Q · Periodic report▲ PositivePro7EYENational Vision Holdings, Inc.National Vision Q2 10-Q: $31.6M Adjusted Operating Income, $20M Buyback, $3.1M RestructuringForm 10-Q · Periodic report▲ Positive8NMTCNeuroOne Medical Technologies CorporationNeuroOne Q3: Revenue Up 16%, But Cash Drops to $2.0M and Going Concern Doubt PersistsForm 10-Q · Periodic report▼ NegativePro8PULMPulmatrix, Inc.Pulmatrix Q2 10-Q: Going Concern Warning, Cash Down to $2.2M, Merger CriticalForm 10-Q · Periodic report▼ NegativePro8YSWYYesway, Inc.Yesway Q2 2026: Revenue up 36%, Adjusted EBITDA up 35%, guidance raised to $235-$245MForm 10-Q · Periodic report▲ PositivePro8SSIISS Innovations International, Inc.SS Innovations Q2 Loss Widens to $2.66M; Going Concern Doubt PersistsForm 10-Q · Periodic report▼ NegativePro8REKRRekor Systems, Inc.Rekor Q2 Loss Narrows, But Going Concern and Nasdaq Delisting Risks LoomForm 10-Q · Periodic report▼ NegativePro8GDSGDS Holdings LtdGDS Swings to Q2 Profit on DayOne Dilution Gain; Raises Full-Year Revenue and Capex GuidanceForm 6-K · Current report▲ PositivePro8TVIVTexas Ventures Acquisition IV CorpSPAC Reports Q2 Net Income of $80K, Confirms Going Concern Through 2027Form 10-Q · Periodic report● NeutralPro7SGRPSPAR Group, Inc.SPAR Group Returns to Profitability in Q2, Raises Full-Year Margin OutlookForm 8-K · Current report▲ Positive7NMTCNeuroOne Medical Technologies CorporationNeuroOne Q3 Revenue Up 16% to $2.0M, Gross Margin Hits 59.9%; Cash Drops to $2.0MForm 8-K · Current report● Neutral7CADLCandel Therapeutics, Inc.Candel Posts Q2 Loss, Holds $201.6M Cash, Targets Q4 BLA FilingForm 8-K · Current report● Neutral7PULMPulmatrix, Inc.Pulmatrix Reports Q2 Loss, Cash Down to $2.2M; Merger with Eos SENOLYTIX on Track for Q3 CloseForm 8-K · Current report▼ Negative7EPRXEupraxia Pharmaceuticals Inc.Eupraxia Reports Durable Symptom Relief in EoE Trial, Including First Odynophagia DataForm 6-K · Current report▲ Positive8SVVSavers Value Village, Inc.Ares Funds Upsize Secondary Offering to 20M Shares at $10.25, a 4.9% DiscountForm 424B5 · Offering▼ NegativePro8CRMDCorMedix Inc.CorMedix Q2 10-Q Reveals Material Weakness and $59M Letter of CreditForm 10-Q · Periodic report▼ NegativePro8MGTXMeiraGTx Holdings plcMeiraGTx Q2 2026: $160.7M Net Income, Bota-vec Acquisition, and FDA Breakthrough DesignationForm 8-K · Current report▲ PositivePro8DKIDarkIris Inc.DarkIris Reports 13.9% Revenue Growth but Flags Going Concern DoubtForm 6-K · Current report▼ NegativePro7DUKRDUKE Robotics Corp.Duke Robotics Q2 Loss Widens to $726K; Cash Runway Extended to 2028Form 8-K · Current report● Neutral8ELMTElmet Group Co.Elmet Group Q2 Revenue Jumps 35% to $66.4M, Backlog Hits Record $131.5MForm 8-K · Current report▲ PositivePro
How Wiseek picks and scores these

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.